Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Glenmark Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532296NSE Symbol: GLENMARKP/E(TTM):31.39
ISIN Demat:INE935A01035Div & Yield %:0.12EPS(TTM):66.4
Book Value(Rs):868.316327Market Cap ( Cr.):58827.58Face Value(Rs):1
    Change Company 
(Rs In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
SOURCES OF FUNDS :      
Share Capital 28.2228.2228.2228.2228.2228.22
Reserves Total 24475.7422942.4017849.2516710.3714781.2913198.05
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds24503.9622970.6217877.4716738.5914809.5113226.27
Secured Loans 298.820.000.000.000.000.00
Unsecured Loans 530.97707.293221.223737.703703.993573.76
Total Debt829.79707.293221.223737.703703.993573.76
Other Liabilities132.10131.94372.58121.32136.61205.65
Total Liabilities25465.8523809.8521471.2720597.6118650.1117005.68
APPLICATION OF FUNDS :      
Gross Block 3743.153392.753183.653026.282848.562595.06
Less : Accumulated Depreciation 1763.971636.501437.701273.951126.07983.11
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 1979.181756.251745.951752.331722.491611.95
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress154.56197.67172.34109.04131.40200.01
Producing Properties0.000.000.000.000.000.00
Investments 15194.9112964.7910332.718559.396989.954713.93
Current Assets, Loans & Advances      
Inventories 1369.311142.691090.21951.66762.39837.50
Sundry Debtors 2550.162484.472505.662678.322488.751835.24
Cash and Bank132.74129.1593.7929.6315.7988.26
Loans and Advances 725.47925.17696.82743.311642.201662.89
Total Current Assets4777.684681.484386.484402.934909.124423.89
Less : Current Liabilities and Provisions      
Current Liabilities 2383.393249.792952.142168.391834.311827.48
Provisions 125.79354.74162.52148.49133.11118.45
Total Current Liabilities2509.183604.543114.662316.881967.411945.92
Net Current Assets2268.501076.941271.822086.052941.712477.97
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets166.59475.611160.251137.471118.721081.34
Deferred Tax Liability224.85309.77213.50214.20265.43276.60
Net Deferred Tax-58.26165.84946.75923.27853.29804.74
Other Assets5926.977648.377001.707167.546011.277197.08
Total Assets25465.8623809.8521471.2620597.6218650.1117005.68
Contingent Liabilities2949.432658.493443.303325.063730.174430.59